Disruption – Talk Bio

Concentra’s Surprise Bid Disrupts Acelyrin-Alumis Merger Plans

2 months ago talkbio0Tagged Acelyrin, Alumis, biopharmaceutical industry, Concentra Biosciences, Disruption, M&A, Merger, Unsolicited Adverse Event

Concentra Biosciences, Acelyrin, Alumis, merger disruption, unsolicited offer, biopharmaceutical industry, M&A

Theratechnologies Warns of Temporary Supply Disruption for EGRIFTA SV in Early 2025 Due to Third-Party Facility Shutdown

7 months ago talkbio0Tagged Disruption, Egrifta, Facility (object), HIV drug, shutdown, sievert, Theratechnologies

Theratechnologies, EGRIFTA SV, supply disruption, third-party facility shutdown, HIV drug, 2025

Coherus Biosciences Addresses Temporary UDENYCA Supply Interruption

7 months ago talkbio0Tagged Biosciences, Biosimilars, Cancer Therapeutic Procedure, Coherus, Disruption, Neulasta, pegfilgrastim, Pharmaceutical Supply Chain, Udenyca, White Blood Cell Count procedure

UDENYCA, Coherus Biosciences, supply interruption, biosimilar, pegfilgrastim, Neulasta, cancer treatment, white blood cell count, pharmaceutical supply chain.